Literature DB >> 15530628

Regression of low-grade squamous intra-epithelial lesions in young women.

Anna-Barbara Moscicki1, Stephen Shiboski, Nancy K Hills, Kimberly J Powell, Naomi Jay, Evelyn N Hanson, Susanna Miller, K Lisa Canjura-Clayton, Sepidah Farhat, Jeanette M Broering, Teresa M Darragh.   

Abstract

BACKGROUND: The aim of this study was to assess the probability of low-grade squamous intra-epithelial lesion (LSIL) regression in young women, and to examine the factors associated with this regression.
METHODS: In a longitudinal study of human papilloma virus (HPV) infection, female adolescents aged 13-22 years were examined every 4 months by cytology, colposcopy, and HPV DNA status. Both prevalent and incident LSIL cases were included in the analysis, with regression defined as at least three consecutive normal Pap smears.
FINDINGS: Median follow-up time from baseline (defined as the time of first LSIL diagnosis) for the 187 women with LSIL was 61 months (IQR 34-80). Median time they had been sexually active at diagnosis was 3.2 years (2.6-6.5). Probability of regression for the entire cohort was 61% (95% CI 53-70) at 12 months and 91% (84-99) at 36 months of follow-up. No associations were found between LSIL regression and HPV status at baseline, sexual behaviour, contraceptive use, substance or cigarette use, incident sexually transmitted infection, or biopsy. Multivariate analysis showed that only HPV status at the current visit was associated with rate of regression, whether infection was caused by one or more viral types (relative hazard=0.3 [95% CI 0.21-0.42], and 0.14 [0.08-0.25], respectively).
INTERPRETATION: The high rate of regression recorded in this study lends support to observation by cytology in the management of LSIL in female adolescents. Negative HPV status was associated with regression, suggesting that HPV testing could be helpful in monitoring LSIL.

Entities:  

Mesh:

Year:  2004        PMID: 15530628     DOI: 10.1016/S0140-6736(04)17354-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  79 in total

Review 1.  Management of low-grade cervical lesions in young women.

Authors:  Susie Lau; Eduardo L Franco
Journal:  CMAJ       Date:  2005-09-27       Impact factor: 8.262

2.  Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Charles Wibbelsman; Teresa M Darragh; Adaleen Powers; Sepideh Farhat; Stephen Shiboski
Journal:  Obstet Gynecol       Date:  2010-12       Impact factor: 7.661

Review 3.  Conservative management of adolescents with abnormal cytology and histology.

Authors:  Anna-Barbara Moscicki
Journal:  J Natl Compr Canc Netw       Date:  2008-01       Impact factor: 11.908

4.  [If it is a public health problem, screen the population].

Authors:  Emilia Bailón Muñoz
Journal:  Aten Primaria       Date:  2009-05-22       Impact factor: 1.137

Review 5.  Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.

Authors:  Lea E Widdice; Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-07-23       Impact factor: 5.012

6.  Human papillomavirus-related gynecologic neoplasms: screening and prevention.

Authors:  Whitfield B Growdon; Marcela Del Carmen
Journal:  Rev Obstet Gynecol       Date:  2008

Review 7.  [HPV infection in women : Diagnostics, treatment and the relevance of vaccination].

Authors:  F Kleinsorge; M Schmidmayr
Journal:  Urologe A       Date:  2018-12       Impact factor: 0.639

8.  Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.

Authors:  Lisa Beth Spiryda; Kara M Whitaker; Amy Messersmith; Carolyn E Banister; Kim E Creek; Lucia A Pirisi-Creek
Journal:  J Low Genit Tract Dis       Date:  2016-01       Impact factor: 1.925

Review 9.  [Human papillomavirus infection. Pathology and molecular pathology].

Authors:  K Sotlar
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

10.  Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.

Authors: 
Journal:  BMJ       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.